Literature DB >> 8723322

Antioxidant defenses in metal-induced liver damage.

R J Sokol1.   

Abstract

Recent investigations have begun to define more clearly the cellular and molecular roles of oxidant stress in mediating the liver injury and fibrosis of metal storage diseases. Because of a variety of perturbations in antioxidant homeostasis in iron and copper overload, restoring the antioxidant balance to normal, or even exceeding normal levels of selected antioxidants, may provide additional protection against liver injury and prevent the progression to fibrosis and cirrhosis. Inasmuch as GSH levels appear to be elevated in livers of experimentally iron-overloaded animals, attempts to increase this antioxidant should perhaps be limited to copper overload conditions in which hepatic GSH is low. Vitamin C (ascorbate) supplementation should probably be avoided in all metal overload states because of its potentiation of radical generation by transition metals. The safety of beta-carotene in alcoholic liver disease has been questioned. Therefore, until more is known about its toxicity in metal overload, beta-carotene may not be an ideal antioxidant for clinical trials. Vitamin E and related compounds, therefore, appear to be the most reasonable antioxidants to test in metal overload states at this time. In the near future, the results of controlled clinical trials of the use of antioxidants in these and other liver disorders will hopefully provide clearer guidelines for their safety and possible use.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8723322     DOI: 10.1055/s-2007-1007217

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  6 in total

1.  Effect of IGF-I on total serum antioxidant status in cirrhotic rats.

Authors:  M García-Fernández; I Castilla-Cortázar; M Díaz-Sánchez; F Díez Caballero; A Castilla; A Díaz Casares; I Varela-Nieto; S González-Barón
Journal:  J Physiol Biochem       Date:  2003-06       Impact factor: 4.158

2.  Thiamine supplementation attenuated hepatocellular carcinoma in the Atp7b mouse model of Wilson's disease.

Authors:  Christian T Sheline
Journal:  Anticancer Res       Date:  2011-10       Impact factor: 2.480

Review 3.  Bioconjugation of oligonucleotides for treating liver fibrosis.

Authors:  Zhaoyang Ye; Houssam S Hajj Houssein; Ram I Mahato
Journal:  Oligonucleotides       Date:  2007

4.  GSTP1, GSTM1, and GSTT1 genetic polymorphisms in patients with cryptogenic liver cirrhosis.

Authors:  Shahrokh Mohammadzadeh Ghobadloo; Bahram Yaghmaei; Valery Bakayev; Hossein Goudarzi; Babak Noorinayer; Farhad Haghighi Rad; Saeed Samiy; Sohrab Aghabozorghi; Mohammad Reza Zali
Journal:  J Gastrointest Surg       Date:  2004 May-Jun       Impact factor: 3.452

5.  Serum vitamin E deficiency among people living with HIV and undergoing antiretroviral therapy at Ho Teaching Hospital, Ghana.

Authors:  Daniel Edem Kpewou; Faustina O Mensah; Collins A Appiah; Huseini Wiisibie Alidu; Vitus Sambo Badii
Journal:  Heliyon       Date:  2021-06-17

6.  Antioxidant effects of insulin-like growth factor-I (IGF-I) in rats with advanced liver cirrhosis.

Authors:  María García-Fernández; Inma Castilla-Cortázar; Matías Díaz-Sanchez; Iñigo Navarro; Juan Enrique Puche; Alberto Castilla; Amelia Díaz Casares; Encarna Clavijo; Salvador González-Barón
Journal:  BMC Gastroenterol       Date:  2005-03-03       Impact factor: 3.067

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.